Acarix AB (publ) (STO:ACARIX)

Market Cap	335.57M +28.2%
Revenue (ttm)	6.92M +21.9%
Net Income	-52.44M
EPS	-0.05
Shares Out	1.24B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	558,183
Average Volume	2,061,346
Open	0.2905
Previous Close	0.2705
Day's Range	0.2760 - 0.2945
52-Week Range	0.1914 - 0.4710
Beta	-0.30
RSI	63.12
Earnings Date	Feb 12, 2026

About Acarix AB

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 8
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ACARIX

Financial Performance

In 2024, Acarix AB's revenue was 6.20 million, a decrease of -0.62% compared to the previous year's 6.24 million. Losses were -66.19 million, -14.97% less than in 2023.